COVID-19 and the Regulation of Health Products – Latest Information

The HPRA will provide information on this dedicated section of our website to keep stakeholders informed of developments related to COVID-19 and the health products we regulate.

Please click on the links below for more information: 

Medicines and Vaccines

Medical Devices 

Clinical Trials and Investigations 

For the latest COVID-19 health information, advice and guidelines, visit and

Contacting the HPRA during the COVID-19 Response

The HPRA reception is open from 8.45am to 12.30pm and from 1.30pm to 4.00pm, Monday to Friday. To contact reception, please call +353-1-6764971.

The vast majority of HPRA staff are currently working remotely. This is in line with Government advice which aims to slow down the spread of the infection. During this period, you can also contact us by e-mail using existing HPRA staff e-mail contacts or via relevant mailboxes. Please also see additional details, including emergency contacts, on our Contact Us page.

We request that you do not correspond with us by post as we will have limited access to physical mail sent to our offices.

If you have any regulatory queries specific to this issue, please e-mail inserting COVID-19 into the subject line.

We have implemented business continuity measures to maintain HPRA operations and ensure minimal disruption to services. Our focus is to continue to operate business as usual, where possible, while protecting the health of our staff and stakeholders.